Cargando…
Protecting Clinical Trial Participants and Protecting Data Integrity: Are We Meeting the Challenges?
Susan Ellenberg discusses alternative approaches towards evaluating data as it accumulates in clinical trials, and to protecting the integrity and preventing undue risks to participants, as the trial continues.
Autor principal: | Ellenberg, Susan S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3373649/ https://www.ncbi.nlm.nih.gov/pubmed/22719230 http://dx.doi.org/10.1371/journal.pmed.1001234 |
Ejemplares similares
-
Protecting against researcher bias in secondary data analysis: challenges and potential solutions
por: Baldwin, Jessie R., et al.
Publicado: (2022) -
Three Steps to Protecting Pediatric Research Participants from Excessive Risks
por: Wendler, David
Publicado: (2006) -
Could an Open-Source Clinical Trial Data-Management System Be What We Have All Been Looking For?
por: Fegan, Greg W, et al.
Publicado: (2008) -
Sharing Individual Participant Data (IPD) within the Context of the Trial Reporting System (TRS)
por: Zarin, Deborah A., et al.
Publicado: (2016) -
Protected area downgrading, downsizing, and degazettement as a threat to iconic protected areas
por: Qin, Siyu, et al.
Publicado: (2019)